Table 1.

Detectable differences for dichotomous outcome measures

Outcome	Tapering/discontinuation	Maintenance treatment	Reference
Remission and no antipsychotics (primary outcome)	39.7%	23.3%	Godtfredsen [21]
Stable remission of psychotic symptoms and max 1-mg haloperidol equivalents (most important secondary outcome measure)	15.4%	4.8%	Wunderink [22]
Percentage in recovery after 7 years (exploratory outcome measure)	33.4%	17.6%	Wunderink [23]